Imaxio Acquires Orphan Drug Indicated for a Congenital Metabolic Disease

News   Jan 22, 2013

 
Imaxio Acquires Orphan Drug Indicated for a Congenital Metabolic Disease
 
 
 

RELATED ARTICLES

Tuberculosis Vaccine Trial Results Offer Potential for BCG Revaccination

News

The study is the first 'prevention of infection' trial conducted for tuberculosis, the world's leading infectious disease killer.

READ MORE

Immune History Influences Flu Vaccine Effectiveness

News

New research on why the influenza vaccine was only modestly effective in recent years shows that immune history with the flu influences a person's response to the vaccine.

READ MORE

Putting the Brain at the Center of Anesthesiology

News

Emery N. Brown explains how statistics and neuroscience improve anesthesiology at the American Association for the Advancement of Science's annual meeting.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE